[1]卢灿钧.2017~2018年我院门诊口服心血管类药物使用情况分析[J].医学信息,2019,(18):121-123.[doi:10.3969/j.issn.1006-1959.2019.18.040]
 LU Can-jun.Analysis of the Use of Oral Cardiovascular Drugs in Outpatients of Our Hospital from 2017 to 2018[J].Medical Information,2019,(18):121-123.[doi:10.3969/j.issn.1006-1959.2019.18.040]
点击复制

2017~2018年我院门诊口服心血管类药物使用情况分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年18期
页码:
121-123
栏目:
调查分析
出版日期:
2019-09-15

文章信息/Info

Title:
Analysis of the Use of Oral Cardiovascular Drugs in Outpatients of Our Hospital from 2017 to 2018
文章编号:
1006-1959(2019)18-0121-03
作者:
卢灿钧
广西中医药大学附属瑞康医院药学部,广西 南宁 530011
Author(s):
LU Can-jun
Department of Pharmacy,Ruikang Hospital,Guangxi University of Traditional Chinese Medicine,Nanning 530011,Guangxi,China
关键词:
门诊西药房口服心血管类药物
Keywords:
Key words:OutpatientWestern pharmacyOralCardiovascular drugs
分类号:
R972
DOI:
10.3969/j.issn.1006-1959.2019.18.040
文献标志码:
A
摘要:
目的 对我院门诊西药房口服心血管类药物使用情况进行分析,为临床合理用药和药品监管提供参考。方法 回顾性分析我院2017年1月~2018年12月门诊西药房口服心血管类药物使用总金额、构成比、排序及DDDS等相关数据。结果 2017年1月~2018年12月我院使用的心血管药物包括抗心绞痛药、抗动脉粥样硬化药、降压药、抗心律失常药、钙通道阻滞药、扩张血管的药物、调节血脂药、抗休克的血管活性药及慢性心功能不全药物的使用总金额、构成百分比及DDDS排序稳定,其中占全年百分比最小的是抗心律失常药,占全年百分比最大的是降压药、钙通道阻滞药、扩张血管的药物;进口(含合资)和国产口服心血管类药物变化不大,但2018年进口(含合资)类药物略有上升;门诊西药房口服心血管类药物使用金额排序前十的药物分别为硝苯地平控释片、阿托伐他汀片、瑞舒伐他汀钙片、苯磺酸左旋氨氯地平片、厄贝沙坦片、盐酸曲美他嗪胶囊、苯磺酸氨氯地平胶囊、厄贝沙坦氢氯噻嗪片、美托洛尔缓释片及氯沙坦钾片,其中从2017~2018年使用金额变化最大的为硝苯地平控释片、阿托伐他汀片及瑞舒伐他汀钙片。结论 我院门诊西药房口服心血管类药物使用频率比较稳定,使用情况合理。
Abstract:
Abstract:Objective To analyze the use of oral cardiovascular drugs in western pharmacies of our hospital, and to provide reference for clinical rational drug use and drug supervision. Methods A retrospective analysis of the total amount, composition ratio, ranking and DDDS of oral cardiovascular drugs used in outpatient western pharmacies from January 2017 to December 2018 in our hospital was retrospectively analyzed. Results From January 2017 to December 2018, cardiovascular drugs used in our hospital included anti-angina drugs, anti-atherosclerotic drugs, antihypertensive drugs, antiarrhythmic drugs, calcium channel blockers, drugs for dilating blood vessels, and regulation. The total amount, composition percentage and DDDS ranking of blood lipid drugs, anti-shock vasoactive drugs and chronic cardiac insufficiency drugs are stable, and the least percentage of the whole year is anti-arrhythmia drugs, and the largest percentage of the whole year is antihypertensive drugs. , calcium channel blockers, drugs that dilate blood vessels; imports (including joint ventures) and domestic oral cardiovascular drugs have not changed much, but imports (including joint ventures) have increased slightly in 2018; outpatient western pharmacies take oral cardiovascular drugs The top ten drugs used for the top ten are nifedipine controlled release tablets, atorvastatin tablets, rosuvastatin calcium tablets, levamlodipine besylate tablets, irbesartan tablets, and trimetazidine hydrochloride capsules,amlodipine besylate capsules, irbesartan hydrochlorothiazide tablets, metoprolol sustained-release tablets and losartan potassium tablets,of which the largest change from 2017 to 2018 is the controlled release tablets of nifedipine, Atorvastatin tablets and rosuvastatin calcium tablets.Conclusion The frequency of oral cardiovascular drugs used in the western pharmacy of our hospital is relatively stable and the use is reasonable.

参考文献/References:

[1]王斌,郑英丽.北京某三甲医院住院药房口服抗高血压药应用分析[J].中国医药导刊,2017(3):291-292. [2]陈伟伟,高润霖,刘力生,等.《中国心血管病报告2016》概要[J].中国循环杂志,2017,32(6):521-530. [3]陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:362-416. [4]邹豪,邵元福,朱才娟,等.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. [5]芦志伟,赵振宇.2015-2017年天津医科大学代谢病医院住院药房口服降糖药使用情况分析[J].现代药物与临床,2018,33(9):2419-2424. [6]姜虹,毕宪初,周跃.基本药品目录实行前后社区高血压用药情况分析[J].上海医药,2014,35(2):41-43. [7]于金玲,魏亚伟.2011-2013年解放军第四六四医院住院药房心血管药物的使用情况分析[J].现代药物与临床,2014,29(4):421-424. [8]王小艺,卢颖,冯晓远,等.基于Meta分析的稳心颗粒治疗心血管疾病的药物经济学评价[J].中国药房,2017,28(5):591-595. [9]陈志磊,刘娜,王方.药物基因组学在心血管疾病药物治疗中的研究进展[J].中国药房,2017,28(26):3741-3744. [10]朱威.社区医院门诊 2 型糖尿病患者口服降糖药物应用调查及分析[J].北方药学,2014,11(10):117-118.

相似文献/References:

[1]吴 刚,孙文武,汪延安.门诊用药错误及防范措施分析[J].医学信息,2019,(02):157.[doi:10.3969/j.issn.1006-1959.2019.02.047]
 WU Gang,SUN Wen-wu,WANG Yan-an.Analysis of Medication Errors and Preventive Measures in Outpatients[J].Medical Information,2019,(18):157.[doi:10.3969/j.issn.1006-1959.2019.02.047]
[2]刘 婷,祖晨曦,王 辉,等.门诊投诉分析及对策研究[J].医学信息,2019,(03):145.[doi:10.3969/j.issn.1006-1959.2019.03.047]
 LIU Ting,ZU Chen-xi,WANG Hui,et al.Outpatient Complaint Analysis and Countermeasure Research[J].Medical Information,2019,(18):145.[doi:10.3969/j.issn.1006-1959.2019.03.047]

更新日期/Last Update: 2019-09-15